TRuE-AD3 supplemental data and PLS
收藏Mendeley Data2026-04-09 收录
官方服务:
资源简介:
These are supplemental data and a plain-language summary to the article titled "Efficacy and Safety of Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3, a Phase 3, Randomized Double-Blind Study", which was published in the Journal of the American Academy of Dermatology



